To view this content, JavaScript must be enabled, and you need the latest version of the Adobe Flash Player.

Download the free Flash Player now!

Get Adobe Flash Player

Highlights

Alexion Receives Highest Healthcare Honors

Alexion Receives Highest Healthcare Honors

Alexion is the proud recipient of two Prix Galien awards – the 2008 Prix Galien USA Award for Best Biotechnology Agent and the 2009 Prix Galien France in the category of medicines for ultra-rare diseases. Both awards recognize Soliris® (eculizumab) and the impact the drug is having on the lives of patients with paroxysmal nocturnal hemoglobinuria (PNH).

Alexion Aims To Develop Life-Changing Therapies

Alexion Aims To Develop Life-Changing Therapies

Alexion is working with physicians and researchers around the world to develop new therapies for patients with severe, life-threatening and often ultra-rare diseases. Learn more about our research and development programs and clinical trials underway.

Alexion Installs Ambitious Solar PV System

Alexion Installs Ambitious Solar PV System

Alexion has a long-standing commitment to energy conservation and to the communities in which it operates. The company recently installed a solar PV system on the rooftop of its corporate headquarters and research facility in Cheshire, Conn. This system will produce more than 329,000 kWh of power annually, resulting in an estimated reduction of 380,000 lbs of CO2 emissions per year.